| Private equity IPOs outperform market |
|
|
| Written by Adrie van der Luijt | |
| Tuesday, 29 April 2008 | |
|
Research provides new evidence on the strong performance of private equity-backed IPOs.
The report by Cass Business School, London, was commissioned jointly by the British Private Equity and Venture Capital Association (BVCA) and the London Stock Exchange (LSE), and covers the period January 1995 to December 2006. The BVCA and the LSE commissioned the Cass Private Equity Centre (CPEC) to assess the attractiveness of the London markets for private equity-backed initial public offerings (IPOs). Spending on R&D The assessment is based on two key aspects of performance. First, the relative importance of different exit routes used by private equity firms for divestment of their holdings. Second, the initial and long-term aftermarket performance of private equity backed IPOs. The study found that private equity-backed IPOs outperform other IPOs by more than 9 per cent one year after their public listing. They also outperform the FTSE ALL Share Index by 20 per cent over the same period. Venture capital-backed IPOs typically spend up to five times as much on R&D as their non-private equity-backed counterparts at the time of flotation. Typical private equity-backed IPOs spend twice as much on capital expenditure in relation to total assets as non private equity-backed companies. Simon Walker, chief executive of the BVCA, said that the research provided more evidence of the way in which private equity is good at building better businesses by growing value. “The figures on spending on R&D and capital investment underline the big contribution that private equity and venture capital make to creating both businesses and an economy that are more innovative,” he added. Health and technology sectors The report also shows that private equity-backed IPOs account for more than 50 per cent of the total number of companies in the consumer services, industrials, healthcare and technology sectors in the main market. The majority of venture capital-backed IPOs are in the health and technology sectors. Out of 1,735 IPOs on the London Stock Exchange Main and AIM markets between 1995 and 2006, private equity-backed IPOs accounted for 22 per cent of the number of IPOs and 27 per cent – or £18.9 billion – of the total sum raised. The average length of time a private equity firm invests in a company before flotation is 4.5 years for venture-capital-backed IPOs and 3.8 years for PE-backed IPOs. IPOs in the Main market perform relatively better than their AIM counterparts. The PE firm typically holds an average of 33.2 per cent in venture capital-backed IPOs and 59.2 per cent in PE-backed IPOs just before flotation. Immediately after flotation, these holdings are at 19.8 per cent and 28.5 per cent respectively, showing the continuing involvement that the original investors have in the business. Complementary relationship Professor Mario Levis, author of the report, said the study showed significant aftermarket performance for private equity-backed IPOs. He explained that such IPOs are more profitable, they are run more efficiently and they invest more in both physical assets and R&D than their non-private equity backed-counterparts. “Investors will increasingly look for such attributes in companies seeking a public listing under the challenging current market conditions,” he added. Nick Langford, head of UK business development for Equity Primary Markets at the London Stock Exchange, said the findings underlined the importance of the complementary relationship between private equity and venture capital and our markets. “In particular, the success of AIM has provided a choice of exit routes catering to companies of different sizes and sectors and at different stages in their development,” Langford concluded. Related articles
Related links |
Subscribe to our weekly newsletter for top jobs, news and more
Digg it!
Post to del.ico.us
Seed in Newsvine
Post to Reddit
Post to Furl
Post to technorati
